Listen
Town Square with Ernie Manouse airs at 3 p.m. CT. Tune in on 88.7FM, listen online or subscribe to the podcast. Join the discussion at 888-486-9677, questions@townsquaretalk.org or @townsquaretalk.
According to research, remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe COVID-19 symptoms. It’s uncertain if the use of remdesivir prevents hospitalization in symptomatic, non-hospitalized patients, who are at high risk for disease progression.
Many believe it's time to start clearing up the confusion and misinformation campaigns.
How do you know if you just have the flu, or if you have COVID?
Which COVID developments you should be paying attention to?
Today, our medical experts help separate fact from fiction when it comes to the latest COVID headlines – whether it's with remdesivir, or any other issue you've heard in the news.
GUESTS:
Dr. Matthew Dacso
- Director of the Center for Global Health Education
- Associate Professor,
Department of Internal Medicine
at the University of Texas Medical Branch (Galveston)
Dr. Jill Weatherhead
- Assistant professor of tropical medicine and infectious diseases
at Baylor College of Medicine
Town Square with Ernie Manouse airs at 3 p.m. CT. Tune in on 88.7FM, listen online or subscribe to the podcast. Join the discussion at 888-486-9677, questions@townsquaretalk.org or @townsquaretalk.
Subscribe to Today in Houston
Fill out the form below to subscribe our new daily editorial newsletter from the HPM Newsroom.
